HC Wainwright & Co. reiterated coverage on ADMA Biologics with a new price target

8/12/21 6:31:31 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

HC Wainwright & Co. reiterated coverage of ADMA Biologics with a rating of Buy and set a new price target of $6.00 from $7.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ADMA

Date	Price Target	Rating	Analyst
7/19/2023	$5.00	Strong Buy	Raymond James
10/13/2022	$5.00	Buy	Mizuho
11/11/2021	$5.00	Outperform → Strong Buy	Raymond James
11/9/2021	$4.50	Overweight	Cantor Fitzgerald
10/26/2021	$6.00 → $5.00	Outperform	Raymond James
8/12/2021	$7.00 → $6.00	Buy	HC Wainwright & Co.
7/6/2021	$10.00 → $7.00	Buy	HC Wainwright & Co.